| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8687899 | NeuroImage: Clinical | 2018 | 6 Pages |
Abstract
The good accuracy to discriminate patients from controls suggests that RS FC could be used as a biomarker with high diagnostic value in future clinical practice to identify mFND patients at the individual level.
Keywords
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Jennifer Wegrzyk, Valeria Kebets, Jonas Richiardi, Silvio Galli, Dimitri Van de Ville, Selma Aybek,